Establishment of Gemcitabine-resistant Mouse Pancreatic Ductal Adenocarcinoma Cell Line and Possible Therapeutic Agents
Anticancer Research · 2026
DOI: 10.21873/anticanres.18076 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Kumiko Miyashita und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan. Hauptthemen laut MEDLINE: Deoxycytidine, Carcinoma, Pancreatic Ductal, Drug Resistance, Neoplasm, Pancreatic Neoplasms.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan.
- Department of Internal Medicine, Kobe Medical Center, Kobe, Japan.
- Department of Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan; horiy@people.kobe-u.ac.jp.
Zitieren
APA
Miyashita, K., Yamashita, K., Miyoshi, M., Nishiyama, T., Ise, Y., Ohsaka, S., Shimizu, K., Nishimura, N., & Hori, Y. (2026). Establishment of Gemcitabine-resistant Mouse Pancreatic Ductal Adenocarcinoma Cell Line and Possible Therapeutic Agents. Anticancer Research. https://doi.org/10.21873/anticanres.18076
Vancouver
Miyashita K, Yamashita K, Miyoshi M, Nishiyama T, Ise Y, Ohsaka S, et al. Establishment of Gemcitabine-resistant Mouse Pancreatic Ductal Adenocarcinoma Cell Line and Possible Therapeutic Agents. Anticancer Research. 2026. doi:10.21873/anticanres.18076
BibTeX
@article{Miyashita2026,
author = {Miyashita, Kumiko and Yamashita, Kimihiro and Miyoshi, Makoto and Nishiyama, Takaaki and Ise, Yuki and Ohsaka, Shun and Shimizu, Kazuya and Nishimura, Noriyuki and Hori, Yuichi},
title = {Establishment of Gemcitabine-resistant Mouse Pancreatic Ductal Adenocarcinoma Cell Line and Possible Therapeutic Agents},
journal = {Anticancer Research},
year = {2026},
doi = {10.21873/anticanres.18076}
}
EUVIMED